Página 2 - Melhores Quimioterapia para cancro do fígado médicos - TOP-39 médicos

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Professor Associado de Oncologia Médica na İstinye University Liv Hospital Topkapı, especializado em tratamentos de câncer de fígado.

• Membro da Sociedade Americana de Oncologia Clínica (ASCO)
• Publicou múltiplos artigos revisados por pares sobre câncer de fígado e resultados de quimioterapia
• Coordenador de Educação para a Subdivisão de Oncologia Médica
• Vasta experiência em medicina interna e oncologia

O Dr. Sridhar P.S. é especialista em radioterapia, com vasta formação e participação em importantes sociedades de oncologia.

• Experiência no tratamento do cancro do fígado com radioterapia
• Membro da Association of Radiation Oncology of India
• Membro da Society for Neuro-Oncology e do Bangalore Oncology Group
• Diplomate of National Board em radioterapia

Realizou mais de 30.000 exames de PET e atendeu 1.000 pacientes com cancro da tiroide – o Dr. Borde traz uma vasta experiência em medicina nuclear para o tratamento do cancro do fígado.

• 12 anos de experiência em medicina nuclear
• Proficiente em terapias com radioiodo e Lu-177 RN
• Artigos publicados em várias revistas médicas
• Trabalha no HCG Manavata Cancer Centre

Apresentou pesquisas sobre câncer de estômago no prestigiado Gastrointestinal Cancer Symposium da ASCO. O Dr. Valame é especialista em terapias alvo, com foco na base molecular do câncer.

• Concluiu o DNB em Oncologia Médica no Indraprastha Apollo Hospital
• Registrar em Oncologia Médica no Jawaharlal Nehru Cancer Hospital
• Ministrou palestras na International Winter School of Oncology
• MD em Medicina Interna pela Shyam Shah Medical College

O Dr. Lalit Banswal realizou mais de 10.000 cirurgias de grande porte, com foco em cirurgia oncológica minimamente invasiva no HCG Manavata Cancer Centre.

• Especializado em cirurgia de câncer gastrointestinal
• Fellowship-treinado no Tata Medical Center, Kolkata
• Publicou vários artigos de pesquisa nacionais e internacionais
• Ex-Professor Assistente no State Cancer Institute e Government Cancer Hospital, Aurangabad

O Dr. Ahmer Arif Shaikh é especializado em câncer oral e preservação de órgãos, com formação de fellowship em Oncologia Cirúrgica de Cabeça e Pescoço.

• 3 anos de experiência em Oncologia Cirúrgica
• Proficiente em grandes cirurgias maxilofaciais e de cabeça e pescoço
• Pesquisador com múltiplas publicações
• Trabalha no HCG Manavata Cancer Centre - Nasik

A Dra. Shruti Kate é especialista em quimioterapia para cancro do fígado, com experiência em tratamentos avançados como imunoterapia e terapia metronómica. Formou-se no Tata Memorial Hospital – um centro oncológico líder na Índia.

• Experiência no tratamento de tumores sólidos, incluindo cancro do fígado
• Membro da ASCO, ESMO e outras prestigiadas sociedades de oncologia
• Apresentou investigação sobre cancro do pulmão na Conferência Mundial sobre Cancro do Pulmão
• Utiliza as técnicas mais recentes, como a imunoterapia, para cancros avançados

O Dr. Bernd Hertenstein traz 32 anos de experiência em oncologia, com especialização em técnicas avançadas de quimioterapia para câncer de fígado na Clínica Bremen-Mitte.

• Qualificado em ablação por radiofrequência do fígado
• Especialista em quimioembolização do fígado
• Realiza transplantes de células-tronco e medula óssea
• Contribuiu para inúmeras publicações em oncologia

O Dr. Raj realizou mais de 50.000 cirurgias oncológicas e participou em mais de 200 ensaios clínicos, trazendo uma vasta experiência em quimioterapia para cancro do fígado no HCG Manavata Cancer Centre.

• 19 anos de experiência em oncologia cirúrgica
• Formado no Tata Memorial Hospital e no Royal College of Surgeons, Edimburgo
• Especialista em oncologia cirúrgica mamária e torácica
• Professor de Superespecialidade DNB em Oncologia Cirúrgica e Cirurgia da Mama